[1]Locationinpatent:experimentalpartRega,MicheleF.;Wu,Bainan;Wei,Jun;Zhang,Ziming;Cellitti,JasonF.;Pellecchia,Maurizio[JournalofMedicinalChemistry,2011,vol.54,#17,p.6000-6013]
1097083-50-5
1096973-86-2
1803581-18-1 | 4-(2-fluoro-3-methoxyphenyl)piperidine hydrochloride | AA01AFGO | MFCD27500904
1803590-17-1 | 1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethan-1-amine dihydrochloride | AA01AFKL | MFCD27500930
1797017-23-2 | 3-[methyl(piperidin-4-yl)amino]propanoic acid dihydrochloride | AA01AFPJ | MFCD27980652
1482000-91-8 | 3-(3-fluoro-4-methoxyphenyl)-1,2,4-thiadiazol-5-amine | AA01AFTV | MFCD21162121
1403993-56-5 | 3-(difluoromethoxy)azetidine | AA01AFYH | MFCD28132440
1803593-29-4 | (2,2-dimethyloxan-4-yl)hydrazine dihydrochloride | AA01AG2B | MFCD27920342
89728-29-0 | 2-chlorocyclohexane-1-carbonitrile | AA01AG6T | MFCD20631632
1343116-48-2 | 2-(1-methyl-1H-pyrazol-4-yl)piperidine | AA01AGBW | MFCD17288510
63167-04-4 | [2-(phenylsulfanyl)phenyl]methanamine | AA01AGHJ | MFCD12191901
1249819-92-8 | 4-(4,5-Dimethyl-4h-1,2,4-triazol-3-yl)butanoic acid | AA01AGLR | MFCD14639464